RC-3095 (TFA)
RC-3095 TFA is a selective bombesin/gastrin releasing peptide receptor (GRPR) antagonist[1]. RC-3095 TFA exerts protective effects by reducing gastric oxidative injury in the arthritic mice[2].
Product Specifications
CAS Number
1217463-61-0
UNSPSC
12352209
Target
Bombesin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rc-3095-tfa.html
Purity
98.92
Solubility
H2O : 40 mg/mL (ultrasonic)
Smiles
O=C([C@H]1CC(C(C=CC=C2)=C2N3)=C3CN1)N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@H](C(N[C@@H](CC(C)C)CN[C@H](C(N)=O)CC(C)C)=O)CC4=CN=CN4)=O)=O)=O)=O)CC5=CNC6=C5C=CC=C6)=O.OC(C(F)(F)F)=O
Molecular Formula
C58H80F3N15O11
Molecular Weight
1220.34
References & Citations
[1]Oliveira PG, et al. Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis. Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis. Arthritis Rheum. 2011 Oct;63 (10) :2956-65.|[2]Roesler R, et al. RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats. Eur J Pharmacol. 2004 Feb 13;486 (1) :35-41.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal MAPKAPK2 Antibody (7H4.2) [Janelia Fluor 669]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-29767JF669 0.2 mL
Mouse Monoclonal MAPKAPK2 Antibody (7H4.2) [Janelia Fluor 669]
Sign In for Pricing
View Details 
RC218682L2V 200 µL
TRAF3 (NM_003300) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 